Crajoinas RO, Polidoro JZ, Carneiro de Morais CP, Castelo-Branco RC, Girardi AC
It also underscores the importance of experienced legal representation for plaintiffs pursuing claims against these pharmaceutical giants
Indiana Discontinues PFAS Disposal Program for Firefighting Foam Indianas program for collecting and disposing of PFAS-laden firefighting foam is set to end on December 30, leaving the state without a designated disposal method
Clinical Evidence for Non-Diabetic GLP-1 Use The landmark STEP trials (20212022) enrolled thousands of non-diabetic adults with overweight or obesity and measured semaglutide's effect on weight loss alone
Although these drugs demonstrated effectiveness in improving blood sugar control and promoting weight loss, lawsuits now allege that GLP-1 receptor agonists may also be associated with severe gastrointestinal injuries, optic nerve complications, and other serious adverse health effects